Multifocal Electroretinogram in Normal Egyptian Population

NCT ID: NCT05323032

Last Updated: 2022-07-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-22

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studying normal subjects to create unique normal database for multifocal electroretinogram (mf-ERG) in specific population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Normal parameters for electroretinogram (ERG) is important in studying specific population, studying normal subjects is important to create specific normal database for each population. This will help in accurate differentiation for various ocular diseases and in research trials.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Disease Healthy Population

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Multifocal electroretinogram in normal population
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal subjects

Normal subjects at banha university that are seeking regular ophthalmic check-up.

Group Type EXPERIMENTAL

Multifocal electroretinogram (mf-ERG) by electroretinogram device

Intervention Type DEVICE

Measurement of mf-ERG parameters with 61 stimulus elements to asses amplitude of waves in nano volt/degree square (nv/deg2) and latency in millisecond (msec) as measured by electroretinogram device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multifocal electroretinogram (mf-ERG) by electroretinogram device

Measurement of mf-ERG parameters with 61 stimulus elements to asses amplitude of waves in nano volt/degree square (nv/deg2) and latency in millisecond (msec) as measured by electroretinogram device.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normal subjects seeking regular ophthalmic check-up at banha university hospital.

Exclusion Criteria

* Any retinal diseases that may affects mf-ERG waves.
* Subjects with best corrected visual acuity less than 0.7 in decimal form at time of examination.
* Refractive errors more than 0.5 diopter as measured by autorefractometer.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Benha University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Abdelshafy

Lecturer of Ophthalmology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmed A Tabl, MD

Role: STUDY_CHAIR

Benha University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ahmed Abdelshafy Tabl

Banhā, Banha, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed A Tabl, MD

Role: CONTACT

01222328766

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed A Tabl

Role: primary

01222328766

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC 5-22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Normal Human Electro-Oculogram
NCT00001610 COMPLETED